BioPharma Dive – AI / Data
Novo uses FDA voucher to win speedy approval of higher-dose Wegovy
The clearance, issued 54 days after an approval submission, gives Novo another chance to claw back market share from Eli Lilly.
The clearance, issued 54 days after an approval submission, gives Novo another chance to claw back market share from Eli Lilly.